Literature DB >> 28926425

The Roles of DNA Methylation in the Stages of Cancer.

K Wyatt McMahon1, Enusha Karunasena, Nita Ahuja.   

Abstract

Next year will mark 60 years since Dr. Leslie Foulds outlined his hypothesis that cancer is "a dynamic process advancing through stages that are qualitatively different," leading the way to our view of cancer progression as we know it today. Our understanding of the mechanisms of these stages has been continuously evolving this past half-century, and there has always been an active discussion of the roles of both genetic and epigenetic changes in directing this progression. In this review, we focus on the roles one particular epigenetic mark-DNA methylation-plays in these various "discontinuous" stages of cancer. Understanding these steps not only gives us a better picture of how this fascinating biological process operates, but also opens the doors to new prognostic biomarkers and therapies against these malignancies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28926425      PMCID: PMC5657558          DOI: 10.1097/PPO.0000000000000279

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  54 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.

Authors:  A Dupressoir; T Heidmann
Journal:  Oncogene       Date:  1997-06-19       Impact factor: 9.867

Review 3.  APC gene hypermethylation and prostate cancer: a systematic review and meta-analysis.

Authors:  Yang Chen; Jie Li; Xiaoxiang Yu; Shuai Li; Xuerong Zhang; Zengnan Mo; Yanling Hu
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

Review 4.  The RASSF1A tumor suppressor.

Authors:  Howard Donninger; Michele D Vos; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2007-09-15       Impact factor: 5.285

5.  DNA methylation markers and early recurrence in stage I lung cancer.

Authors:  Malcolm V Brock; Craig M Hooker; Emi Ota-Machida; Yu Han; Mingzhou Guo; Stephen Ames; Sabine Glöckner; Steven Piantadosi; Edward Gabrielson; Genevieve Pridham; Kristen Pelosky; Steven A Belinsky; Stephen C Yang; Stephen B Baylin; James G Herman
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

6.  Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

Authors:  Nadia Harbeck; Inko Nimmrich; Arndt Hartmann; Jeffrey S Ross; Tanja Cufer; Robert Grützmann; Glen Kristiansen; Angelo Paradiso; Oliver Hartmann; Astrid Margossian; John Martens; Ina Schwope; Antje Lukas; Volkmar Müller; Karin Milde-Langosch; Jörg Nährig; John Foekens; Sabine Maier; Manfred Schmitt; Ralf Lesche
Journal:  J Clin Oncol       Date:  2008-08-18       Impact factor: 44.544

7.  SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.

Authors:  Maria Chimonidou; Areti Strati; Nikos Malamos; Vasilis Georgoulias; Evi S Lianidou
Journal:  Clin Chem       Date:  2012-11-07       Impact factor: 8.327

8.  DNA methylation markers for diagnosis and prognosis of common cancers.

Authors:  Xiaoke Hao; Huiyan Luo; Michal Krawczyk; Wei Wei; Wenqiu Wang; Juan Wang; Ken Flagg; Jiayi Hou; Heng Zhang; Shaohua Yi; Maryam Jafari; Danni Lin; Christopher Chung; Bennett A Caughey; Gen Li; Debanjan Dhar; William Shi; Lianghong Zheng; Rui Hou; Jie Zhu; Liang Zhao; Xin Fu; Edward Zhang; Charlotte Zhang; Jian-Kang Zhu; Michael Karin; Rui-Hua Xu; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-26       Impact factor: 11.205

9.  Regulation of alternative polyadenylation by genomic imprinting.

Authors:  Andrew J Wood; Reiner Schulz; Kathryn Woodfine; Katarzyna Koltowska; Colin V Beechey; Jo Peters; Deborah Bourc'his; Rebecca J Oakey
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

Review 10.  The role of genomic imprinting in biology and disease: an expanding view.

Authors:  Jo Peters
Journal:  Nat Rev Genet       Date:  2014-06-24       Impact factor: 53.242

View more
  11 in total

1.  Hypermethylation of the G protein-coupled receptor kinase 6 (GRK6) promoter inhibits binding of C/EBPα, and GRK6 knockdown promotes cell migration and invasion in lung adenocarcinoma cells.

Authors:  Sumei Yao; Dandan Wu; Jinliang Chen; Peng Wang; Xuedong Lv; Jianan Huang
Journal:  FEBS Open Bio       Date:  2019-03-19       Impact factor: 2.693

2.  Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma.

Authors:  Raimonda Kubiliūtė; Kristina Žukauskaitė; Algirdas Žalimas; Albertas Ulys; Rasa Sabaliauskaitė; Arnas Bakavičius; Arūnas Želvys; Feliksas Jankevičius; Sonata Jarmalaitė
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-23       Impact factor: 4.553

3.  High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.

Authors:  Jeong-Woo Oh; Yun Jeong Oh; Suji Han; Nam-Gu Her; Do-Hyun Nam
Journal:  Cancers (Basel)       Date:  2021-01-20       Impact factor: 6.639

4.  Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis.

Authors:  Hui Zhang; Chenxin Xu; Chen Shi; Junying Zhang; Ting Qian; Zhuo Wang; Rong Ma; Jianzhong Wu; Feng Jiang; Jifeng Feng
Journal:  J Transl Med       Date:  2021-03-05       Impact factor: 5.531

5.  Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.

Authors:  Mourad Assidi; Fatimah M Yahya; Maryam H Al-Zahrani; Razan Elkhatib; Ali Zari; Aisha Elaimi; Jaudah Al-Maghrabi; Ashraf Dallol; Abdelbaset Buhmeida; Muhammad Abu-Elmagd
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 6.  The Epigenetic Progenitor Origin of Cancer Reassessed: DNA Methylation Brings Balance to the Stem Force.

Authors:  Marco Bruschi
Journal:  Epigenomes       Date:  2020-05-28

7.  High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.

Authors:  Teoman Deger; Ruben G Boers; Joost Gribnau; Saskia M Wilting; Vanja de Weerd; Lindsay Angus; Marjolijn M J van der Put; Joachim B Boers; Z Azmani; Wilfred F J van IJcken; Dirk J Grünhagen; Lisanne F van Dessel; Martijn P J K Lolkema; Cornelis Verhoef; Stefan Sleijfer; John W M Martens
Journal:  Clin Epigenetics       Date:  2021-10-20       Impact factor: 6.551

8.  Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation.

Authors:  Sumei Yao; Xinming Chen; Jinliang Chen; Yangbo Guan; Yifei Liu; Jianrong Chen; Xuedong Lv
Journal:  Cancer Cell Int       Date:  2018-12-22       Impact factor: 5.722

Review 9.  Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.

Authors:  Janhavi R Raut; Zhong Guan; Petra Schrotz-King; Hermann Brenner
Journal:  Clin Epigenetics       Date:  2020-08-10       Impact factor: 6.551

10.  Epigenetic Deregulation of Telomere-Related Genes in Newly Diagnosed Multiple Myeloma Patients.

Authors:  Samrat Roy Choudhury; Cody Ashby; Fenghuang Zhan; Frits van Rhee
Journal:  Cancers (Basel)       Date:  2021-12-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.